Announcement

14
MARCH
2016


Category Label


Client Announcements

Frenkel Topping Grp : FCA Permissions Received

  •  
  •   14 March 2016

RNS Number : 9782R

Frenkel Topping Group PLC

14 March 2016

 

 

Frenkel Topping Group plc

("Frenkel Topping" or "the Company")

 

FCA Permissions Received

 

Frenkel Topping (AIM: FEN), a specialist independent financial advisor and asset manager focussed on asset protection for vulnerable clients, announces that the FCA has approved its recent application for a variation of permissions. As a result, the Company is now able to act as a discretionary investment manager with full retail permissions.

 

Richard Fraser, Chief Executive Officer commented: "The Company can now press on and deliver its transformational business plan in line with previous guidance given to the market. We are delighted to be able to now fully implement the new plan."

 

For further information:

 

Frenkel Topping Group plc

www.frenkeltopping.co.uk

Richard Fraser, Chief Executive Officer

Tel: 0161 886 8000

Julie Dean, Chief Financial Officer

 

 

 

Shore Capital

Tel: 020 7408 4090

Patrick Castle/Mark Percy

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or frenkeltopping@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Nick Rome

Mob: 07748 325 236

 

 

About Frenkel Topping: www.frenkeltopping.co.uk

Frenkel Topping provides specialist independent financial advice focussed on asset protection for clients. The specialist independent financial adviser has a market leading position providing advice and fund management services for personal injury trusts and clinical negligence awards and is well placed to provide services to a wider customer base.

 

The Company provides a range of wealth management services including bespoke investment portfolios, financial and tax planning. It is focused on increasing its assets under management by growing the number of fee earners who are qualified to provide benefits protection for a variety of needs as the Company adds to its personal injury and clinical negligence specialism.

 

It has a national presence with offices in Manchester, Birmingham, Bristol, Cardiff, London and Leeds and has relationships and infrastructure in place to further grow its reach and target markets.

 

 

 


This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCSFMFSLFMSEED

;